Genomic Considerations in the Treatment of Thyroid Carcinoma.
Hattum CJ, Elsey RJ, Meissner T, Spanos WC.
JCO Oncol Pract. 2024;20(7):873-875.
https://www.doi.org/10.1200/OP.24.00198
Polycystic ovary syndrome
Stener-Victorin E, Teede H, Norman RJ, et al. P
Nat Rev Dis Primers. 2024 Apr 18;10(1):27.
https://www.doi.org/10.1038/s41572-024-00511-3
Graves disease: latest understanding of pathogenesis and treatment options. Nat Rev Endocrinol.
Lanzolla G, Marinò M, Menconi F.
Published online July 22, 2024.
doi:10.1038/s41574-024-01016-5
What Is Carcinoid Syndrome? A Critical Appraisal of Its Proposed MediatorsMulders MCF, de Herder WW, Hofland J.Endocr Rev. 2024 May 7;45(3):351-360.
doi: 10.1210/endrev/bnad035
Treating Primary Aldosteronism-Induced Hypertension: Novel Approaches and Future Outlooks.Mullen N, Curneen J, Donlon PT, et al.
Endocr Rev. 2024 Jan 4;45(1):125-170.
doi: 10.1210/endrev/bnad026
Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia
Kyriakie Sarafoglou, Mimi S Kim, Maya Lodish, et al.
N Engl J Med. 2024 Jun 2.
doi: 10.1056/NEJMoa2404655
Comentarios recientes